NCT00507065View on ClinicalTrials.gov

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

PHASE3CompletedINTERVENTIONAL
Enrollment

329

Participants

Timeline

Start Date

May 28, 2003

Primary Completion Date

March 24, 2004

Study Completion Date

March 24, 2004

Conditions
ADHD
Interventions
DRUG

Mixed salts of a single-entity amphetamine (ADDERALL XR)

DRUG

Placebo

Trial Locations (1)

Unknown

New York University - Child Study Center, New York

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY